Tailoring treatments for kidney injury in patients with cirrhosis
Personalizing Therapies for Acute Kidney Injury in Cirrhosis
This study is looking to make kidney injury treatments better for people with liver disease by tailoring the care to each person's unique needs, so they can get the best possible results.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11074115 on NIH RePORTER |
What this research studies
This research focuses on improving treatment for patients with acute kidney injury related to cirrhosis by personalizing therapy based on individual patient characteristics. Current guidelines recommend a standard treatment that may not be suitable for all patients, potentially leading to complications. The study aims to identify different subtypes of acute kidney injury and their responses to treatment using clinical data and advanced imaging techniques. By understanding these differences, the goal is to optimize treatment plans and improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with acute kidney injury associated with cirrhosis.
Not a fit: Patients without acute kidney injury or those with cirrhosis but not experiencing kidney complications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer treatment strategies for patients suffering from acute kidney injury due to cirrhosis.
How similar studies have performed: Previous studies have shown promise in personalizing treatments for similar conditions, indicating that this approach could be beneficial.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Allegretti, Andrew S — Massachusetts General Hospital
- Study coordinator: Allegretti, Andrew S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.